Metraipolis › archive › dc_cd1f86e615c0
From Trials to Treatment: Current Evidence Supporting Faricimab Use in nAMD and DME — Europe PMC PMID:42795729
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42795729
- DOI
- 10.3390/jcm15186956
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T22:59:20.370Z
- SHA-256 of the archived text
e4924a358857414fef48059e1bec00f91dea7e0d0acbd1f84e26cc5c4e824ec5- Stable URL of this page
https://metraipolis.com/documento/dc_cd1f86e615c0
How to cite
From Trials to Treatment: Current Evidence Supporting Faricimab Use in nAMD and DME — Europe PMC PMID:42795729 — Europe PMC (en), https://europepmc.org/article/MED/42795729 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd1f86e615c0 (Metraipolis archive dc_cd1f86e615c0, sha256 e4924a358857414fef48059e1bec00f91dea7e0d0acbd1f84e26cc5c4e824ec5)
BibTeX
@misc{dccd1f86e615c0,
title = {From Trials to Treatment: Current Evidence Supporting Faricimab Use in nAMD and DME — Europe PMC PMID:42795729},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42795729},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd1f86e615c0; sha256 e4924a358857414fef48059e1bec00f91dea7e0d0acbd1f84e26cc5c4e824ec5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795729. Agents can read the archived copy with the MCP tool read_document.